You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

KAITLIB FE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Kaitlib Fe patents expire, and what generic alternatives are available?

Kaitlib Fe is a drug marketed by Lupin Ltd and is included in one NDA.

The generic ingredient in KAITLIB FE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for KAITLIB FE?
  • What are the global sales for KAITLIB FE?
  • What is Average Wholesale Price for KAITLIB FE?
Summary for KAITLIB FE
Drug patent expirations by year for KAITLIB FE

US Patents and Regulatory Information for KAITLIB FE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd KAITLIB FE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 203448-001 Dec 17, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.